146 related articles for article (PubMed ID: 25649199)
21. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
[TBL] [Abstract][Full Text] [Related]
22. N-(3,5-dimethylphenyl)-3-methoxybenzamide (A(3)B(5)) targets TRP-2 and inhibits melanogenesis and melanoma growth.
Lee EJ; Lee YS; Hwang S; Kim S; Hwang JS; Kim TY
J Invest Dermatol; 2011 Aug; 131(8):1701-9. PubMed ID: 21525883
[TBL] [Abstract][Full Text] [Related]
23. Biology of tumor progression in human melanocytes.
Herlyn M; Clark WH; Rodeck U; Mancianti ML; Jambrosic J; Koprowski H
Lab Invest; 1987 May; 56(5):461-74. PubMed ID: 3553733
[TBL] [Abstract][Full Text] [Related]
24. Overcoming melanoma drug resistance through metabolic targeting?
Smalley KS
Pigment Cell Melanoma Res; 2013 Nov; 26(6):793-5. PubMed ID: 24152044
[No Abstract] [Full Text] [Related]
25. Melanoma stem cells.
Roesch A
J Dtsch Dermatol Ges; 2015 Feb; 13(2):118-24. PubMed ID: 25631128
[TBL] [Abstract][Full Text] [Related]
26. Melanoma progression in a changing environment.
van Kempen LC; van Muijen GN; Ruiter DJ
Eur J Cell Biol; 2007 Feb; 86(2):65-7. PubMed ID: 17241688
[No Abstract] [Full Text] [Related]
27. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
Boone B; Haspeslagh M; Brochez L
J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
[TBL] [Abstract][Full Text] [Related]
28. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
30. MITF pathway mutations in melanoma.
Yokoyama S; Salma N; Fisher DE
Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
[No Abstract] [Full Text] [Related]
31. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Proliferation of Melanoma Cells and Mesenchymal Stem Cells in Co-Culture and Contribution of Experimental Conditions into Interpretation of the Results.
Kandarakov OF; Kopantseva EE; Belyavsky AV
Bull Exp Biol Med; 2016 Nov; 162(1):127-133. PubMed ID: 27882459
[TBL] [Abstract][Full Text] [Related]
33. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A
Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121
[TBL] [Abstract][Full Text] [Related]
34. Learning the ABCs of melanoma-initiating cells.
Zabierowski SE; Herlyn M
Cancer Cell; 2008 Mar; 13(3):185-7. PubMed ID: 18328422
[TBL] [Abstract][Full Text] [Related]
35. Role of TGF-β in melanoma.
Busse A; Keilholz U
Curr Pharm Biotechnol; 2011 Dec; 12(12):2165-75. PubMed ID: 21619542
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta in cutaneous melanoma.
Javelaud D; Alexaki VI; Mauviel A
Pigment Cell Melanoma Res; 2008 Apr; 21(2):123-32. PubMed ID: 18426405
[TBL] [Abstract][Full Text] [Related]
37. Decreased melanoma proliferation and cell survival: turn down your SOX10.
Loftus SK
Pigment Cell Melanoma Res; 2013 Jan; 26(1):3-4. PubMed ID: 23387001
[No Abstract] [Full Text] [Related]
38. Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?
Brinckerhoff CE
J Cell Physiol; 2017 Oct; 232(10):2674-2678. PubMed ID: 28078710
[TBL] [Abstract][Full Text] [Related]
39. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.
Voon DC; Wang H; Koo JK; Nguyen TA; Hor YT; Chu YS; Ito K; Fukamachi H; Chan SL; Thiery JP; Ito Y
Stem Cells; 2012 Oct; 30(10):2088-99. PubMed ID: 22899304
[TBL] [Abstract][Full Text] [Related]
40. Effect of prostaglandin A1 on proliferation and telomerase activity of human melanoma cells in vitro.
Franzese O; Comandini A; Cannavò E; Pepponi R; Falcinelli S; Graziani G; Bonmassar E
Melanoma Res; 1998 Aug; 8(4):323-8. PubMed ID: 9764807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]